Brief: Adial Pharmaceuticals Completes Successful Eop2 FDA Meeting

Azora Therapeutics

06/08/2025 13:22

Aug 6 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:

ADIAL PHARMACEUTICALS COMPLETES SUCCESSFUL EOP2 FDA MEETING

ADIAL PHARMACEUTICALS INC - TO ADVANCE AD04 INTO PHASE 3 FOR ALCOHOL USE DISORDER

Source text: ID:nGNX8xNhZn

Further company coverage: ADIL.O

 ((Reuters.Briefs@thomsonreuters.com;))